mRNA |
navitoclax:MST-312 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.031 |
0.4 |
mRNA |
AKT inhibitor VIII |
GDSC1000 |
pan-cancer |
AAC |
-0.03 |
0.4 |
mRNA |
DBeQ |
CTRPv2 |
pan-cancer |
AAC |
0.03 |
0.4 |
mRNA |
YM201636 |
GDSC1000 |
pan-cancer |
AAC |
-0.027 |
0.4 |
mRNA |
ibrutinib |
CTRPv2 |
pan-cancer |
AAC |
0.034 |
0.4 |
mRNA |
Cytarabine |
CTRPv2 |
pan-cancer |
AAC |
-0.023 |
0.4 |
mRNA |
Topotecan |
CTRPv2 |
pan-cancer |
AAC |
-0.026 |
0.4 |
mRNA |
carboplatin:UNC0638 (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.03 |
0.4 |
mRNA |
lovastatin |
CTRPv2 |
pan-cancer |
AAC |
0.03 |
0.4 |
mRNA |
tubastatin A |
CTRPv2 |
pan-cancer |
AAC |
0.041 |
0.4 |